According to the company this investment will be used to help to accelerate Chemigraphic’s international growth and drive continued development of its technology and expertise, particularly in the fast-growing med-tech sector.
Headquartered in Crawley’s Manor Royal business park, with a sourcing office in China, Chemigraphic builds complex products for a wide range of specialist UK and global technology brands, from conception to production, supporting them at every stage of their product lifecycle.
NVM Private Equity is independently owned and is a generalist investor, managing approximately £430 million of funds.
Peter Hodson and David Rolfe led the investment for NVM and Hodson joined the Chemigraphic board upon completion.
According to Chris Wootton, CEO of Chemigraphic: “Chemigraphic has a fabulous customer base and is extremely well placed to become a significant global provider of Electronic Manufacturing Services (EMS). We are delighted that NVM shares our vision and has decided to invest in and back the team. The investment will enable us to implement planned strategic investments in our global footprint and hence capitalise on a number of extremely exciting growth opportunities. We are very much looking forward to partnering with the NVM team as we embark upon this next exciting phase in our development”.
In response, Peter Hodson, Investment Partner of NVM Private Equity, said: “Chemigraphic has generated a lot of momentum since Chris joined the company two years ago benefiting from his focus on operational excellence and proactive business development. Chemigraphic’s current customer base is highly committed to the company, having benefitted from market leading service levels and product expertise. We are delighted to be coming on board at this exciting stage in the company's development.”
